China Good Doctor · Human's Good Friend

Reduce suffering for patients with malignant tumors and prolong life!

Chairman of the Tumor Hyperthermia Professional Committee of the China Anti-Cancer Association visits for exchange

　　This time, Good Doctor Medical brought its technically advanced new generation intraperitoneal hyperthermia treatment machine to the 27th National Clinical Oncology Conference and the 2024 Chinese Clinical Oncology Society (CSCO) Academic Annual Meeting, exchanging ideas with directors of oncology departments from across the country. It seemed like a silent hero, showcasing its powerful capabilities. The representatives of Good Doctor at the exhibition confidently introduced the advanced technologies independently developed by the intraperitoneal hyperthermia treatment machine and effective treatment plans for late-stage diffuse pleural and abdominal metastatic cancer. They spoke eloquently, with light in their eyes, and every detail highlighted professionalism and excellence.

　　 The Good Doctor intraperitoneal hyperthermia treatment machine became the focus at the shining CSCO exhibition. It is not just a machine, but a symbol of hope, delivering a satisfactory answer for the innovative development of the field of tumor hyperthermia. It will bring new vitality to countless patients, prolong life, and improve quality of life. The Good Doctor intraperitoneal hyperthermia treatment machine uses puncture technology or postoperative indwelling catheter technology to automatically heat the hyperthermia treatment liquid or cancerous effusion within the treatment machine, establishing circulation through a closed-loop pipeline, achieving infusion of the treatment liquid under the dynamic monitoring and feedback control of a computer. It maintains a constant temperature during the treatment time, effectively killing tumor cells, and comprehensively curbing the recurrence of cancerous effusion. It successfully solves clinical issues such as unstable infusion temperature, poor thermal uniformity in the cavity, and complex operations, avoiding a series of sequelae commonly associated with traditional therapies, such as encapsulation, adhesion, and intestinal obstruction.

　　During the treatment process, physiological saline and chemotherapy drugs are first heated to the preset temperature on the infusion machine, and the infusion machine continuously circulates them into the cavity. The temperature at the outlet and inlet is monitored through a temperature measurement system, ensuring that the temperature within the cavity is maintained at 42°C to 42.5°C for about 60 minutes to maintain effective treatment temperature, fully utilizing the thermal killing mechanism to thermally cleanse the metastatic cancer cells widely planted on the serosa. Based on the metabolic disorders and genetic material damage characteristics of cancer cells after hyperthermia, chemotherapy drugs with thermal sensitization effects are added to induce cancer cells to stop dividing and undergo apoptosis, eliminating the lesions that cause malignant effusion, allowing the biological membrane to be rapidly repaired, achieving the goal of effectively treating cancerous effusion.

Exchange clinical treatment plans with directors of oncology departments from across the country

　　Today, the Good Doctor intraperitoneal hyperthermia treatment machine has been widely used in major hospitals in our country and in foreign medical fields, bringing good news to countless patients. However, the Good Doctor team has not stopped their progress; they continue to dedicate themselves to technological innovation and upgrades, contributing their strength to the development of the medical cause.

　　In the struggle between humans and advanced malignant tumors, malignant effusions such as pleural effusion and abdominal effusion are common complications. The traditional solution is to repeatedly drain the effusion to alleviate its occupying effect, but this approach can lead to faster and greater production of pleural and abdominal effusions, ultimately resulting in patients continuously losing large amounts of protein, electrolytes, and other nutrients, leading to deterioration and death. While simple hyperthermia or chemotherapy has a killing effect on tumor cells, it is difficult to completely eradicate tumor cells within the limits of the body's tolerance. On the other hand, the initial hyperthermia infusion had uneven internal temperatures, the infusion liquid did not flow, and harmful substances in the body could not be completely eliminated, leading to poor clinical outcomes.

　　 The mechanism of the Good Doctor thermal perfusion treatment machine is that tumor tissues are more sensitive to heat than normal tissues. Heating has a direct killing effect on cancer cells, and sub-hyperthermia at 42°C to 42.5°C can induce apoptosis and necrosis in tumor cells. The combined effect of 42°C for 60 minutes can cause the cell death rate to increase exponentially, showing a significant inactivation effect on malignant tumors. On the other hand, perfusion drug delivery can increase the local tissue concentration of drugs. High concentrations of chemotherapy drugs can effectively increase the chances of killing tumor cells, thereby better exerting anti-cancer effects.

　　The road of independent research and development has never been smooth, but they have never backed down. For over a decade, they have continuously innovated. The Good Doctor team, with reverence and dedication to medicine, has ignited the flame of innovation with their unyielding perseverance and sparks of wisdom. They have deeply cultivated the field of tumor hyperthermia medicine, constantly exploring the unknown, bravely climbing to new heights, and turning countless impossibilities into possibilities. From the initial concept to repeated experiments and improvements, and finally to the results, every step embodies their hard work and dedication. The technological research and development confidence that Good Doctor possesses today is not only a breakthrough in technology but also a respect and guardianship of life. They have brought new hope to cancer patients and injected strong momentum into the development of medicine. In the future, Good Doctor will continue to forge ahead, just as the theme of this CSCO conference mentions "Patient-centered, sharing the future," making greater contributions to human health. Finally, I wish the "27th National Clinical Oncology Conference and 2024 CSCO Academic Annual Meeting" a complete success.

　　 Good Doctor·Thermal perfusion takes it as its mission to reduce the suffering of patients with malignant tumors and prolong life.